CJC1295 (without DAC) + Ipamorelin (peptide blend)

CJC-1295 No DAC / Ipamorelin Blend 5/5mg

A research peptide blend combining two synthetic peptides studied in cellular biology and biochemical research literature. Each vial contains 5mg CJC-1295 (No DAC) and 5mg Ipamorelin (10mg total peptide content) in lyophilized form

Product Specifications

• Composition: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin (10mg total)
• Form: Lyophilized powder
• Vial Size: 10mg total in 3mL glass vial

About the Compounds

CJC-1295 (No DAC) — also known as Modified GHRH (1-29) — is a synthetic 30-amino acid peptide analog of human growth hormone-releasing hormone (GHRH). The compound represents a modified version of GHRH (1-29) with four amino acid substitutions (D-Ala², Gln⁸, Ala¹⁵, Leu²⁷) that enhance peptide stability and resistance to enzymatic degradation compared to native GHRH sequences. Unlike CJC-1295 with DAC, this variant does not include the Drug Affinity Complex modification, resulting in a shorter peptide half-life characteristic. CJC-1295 (No DAC) has been studied in cellular research literature examining GHRH receptor pharmacology and peptide chemistry.

Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) belonging to the growth hormone secretagogue (GHS) class of research peptides. Originally developed as a research compound for studying ghrelin receptor (GHS-R1a) pharmacology and pituitary cellular biology, Ipamorelin is notable in research literature for its selective receptor binding profile in cellular research applications.

Research Context

This blend is supplied for laboratories conducting comparative cellular research involving the two component peptides. The combined formulation allows researchers to study CJC-1295 (No DAC) and Ipamorelin within a single sample preparation, streamlining laboratory workflows for parallel and comparative peptide research investigations involving GHRH receptor and growth hormone secretagogue receptor research.

Foundational research on each component compound is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Health’s PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed studies on each compound independently.

This product is supplied exclusively for in vitro research and laboratory investigation by qualified researchers in appropriate research environments.